Stress ulceration is usually considered a mucosal abnormality of the oesophagus, stomach or duodenum in the critically ill. It is found to a varying degree in all such patients. Only about onequarter of lesions are associated with blood loss and less than 5% need resuscitation and treatment. However, because treatment of established bleeding is unsatisfactory, and associated with a high mortality, prophylactic measures are usually employed. These include optimising gastric mucosal blood flow and oxygen delivery, correcting coagulation abnormalities and treating underlying infection. Enteral feeding should also be employed whenever possible. Other prophylactic measures currently used involve raising gastric pH above 4, with either antacids or H 2 receptor antagonists. This is best achieved by measuring the gastric pH hourly and titrating it against an appropriate dose of either type of drug or a combination of both. Newer drugs, such as omeprazole, sucralfate and prostaglandins, are proving very successful in the treatment and prevention of gastric and duodenal ulcers and may prove even more effective than currently available agents.
incidence of acute lesions in the stomach, duodenum and oesophagus. 8 These may include Cushing's ulcer, which is classically associated with coma from any cause. 9 Although the Cushing's ulcer may not be part of the normal spectrum of stress ulceration,1O both lesions may exist in the one patient.
(b) Burns
Stress ulceration commonly occurs in patients with burns involving more than 35!1lo of the body surface. II Curling had, as early as 1842, described massive haemorrhage from duodenal ulcers occurring as a complication of severe burns. The characteristic Curling's ulcer is circumscribed, up to 2 cm in diameter, and occurs in the first or second part of the duodenum. They usually occur about 72 hours after the burn, often in association with more typical stress ulceration.11 (c) Fulminant hepatic failure Fulminant hepatic failure is often complicated by acute gastrointestinal lesions and bleeding. 12 
(d) Sepsis
Stress ulceration invariably accompanies severe sepsis. 13 • 14 The lesions worsen while the sepsis persists and improves dramatically when focal infection and septicaemia are controlled. 13 Although the exact aetiology is unknown, marked reduction in gastric pH resistant to usual therapy is a feature. 13.1)
(e) Drugs
Although drugs associated with erosive gastritis are not usually given to seriously ill patients, they are an important cause of upper gastrointestinal bleeding. The most common are asplfJn, other non-steroidal antiinflammatory drugs and alcohol. Lesions induced by these agents are located mainly in the fundus of the stomach and are morphologically identical to stress ulceration caused by other factors.16
(f) Reactivation of pre-existent Ulcer Diathesis
This is not strictly part of the stress ulceration syndrome. However, up to 10!llo of the population has at one stage developed a chronic peptic ulcer l7 and reactivation of the ulcer may be related to the pathogenesis of stress ulceration. It is important in Intensive Care to differentiate between these two types of Anaesthesia and Intensive Care. Vol. 13 . No. 3, August, /985 ulceration. They have markedly different prognostic and therapeutic implications.
(g) Miscellaneous
Patients who are profoundly hypothermic have been known to develop ulcers. 18 Furthermore, the presence of a nasogastric tube with suction has the potential for causing gastric erosions. 6 
PATHOLOGY
With the use of serial endoscopy, the mucosal changes of stress ulceration have been well described. 2 . 14 The earliest lesion is extensive hyperaemia and focal areas of pallor. Small petechiae and discrete (1-2 mm) shallow erosions usually develop within 24 hours, these become larger and more numerous by 48 hours. The fundus of the stomach is most commonly affected. Sometimes this extends to antral, duodenal and oesophageal involvement. The superficial erosion can then progress to discrete gastric or duodenal ulcers with or without overt bleeding. Rarely, small intestinal or colonic ulcers develop in association with shock or sepsis. This is probably as a result of severe and generalised ischaemia which would also affect most other organs. 17 Histological changes in the affected areas include necrosis of the superficial epithelium with underlying haemorrhage and infiltration of polymorphs. 2 . 23 With deeper ulceration, tissue destruction may extend to the serosa.
As the patient recovers, the superficial erosions and mucosal abnormalities disappear within 4 days l.2 and more extensive lesions by 10 to 14 days. 16 The remarkable reparative capacity of these tissues is related to their high cell turnover, the gastric lining being renewed every few days. 2 Although the aetiology of stress ulceration is not completely understood, there are at least three important factors,17 (i) gastric acid and pepsin; (ii) altered gastric blood flow; and (iii) increased mucosal permeability (Table I) .
Gastric acid is known to play a key role in the formation of stress ulceration but the preservation of gastric mucosal integrity is also important. Integrity depends on blood flow, mucosal permeability and the secretory status of the mucosa. 7.17.19 It is generally agreed that while mucosal ischaemia is the major inciting event in the pathogenesis of acute stress ulceration, the presence of luminal acid and pepsin is necessary for overt ulceration. 17 
Gastric acid and pepsin
Stress ulceration will only occur in the presence of acid,2° as it does not occur when the pH is above 7. 16 This is the basis for prophylactic treatment with antacids and H 2 -receptor antagonists. However, the importance of hypersecretion of acid is debatable.I.20-22 Apart from stress ulceration associated with neurogenic causes and burns,s.1I there is no evidence that increased quantities of acid or pepsin are produced in critically ill patients. 13 In fact, there is a decrease in acid secretion when gastric mucosal blood flow decreases. 2o . 23 Normally, the active secretion of acid on the luminal surface of the stomach is associated with an equal amount of alkali on the serosal surface ~or in the gastric venous blood. 24 Alkalinisation prevents marked decreases in the intramural pH and decreases the risk of ulceration. 23 How studies of stress ulceration are interpreted depends on whether intraluminal or intramural pH is measured. 21 Although luminal acid is essential for the development of gastric ulceration, damage is probably related more to the way in which the stomach deals with or disposes of the back-diffusing hydrogen ions; that is, intramural acidity. In summary, it appears that a critical amount of luminal acid and pepsin is necessary for ulceration to develop, which is variable and dependent on the underlying clinical condition .17
Gastric mucosal blood flow
As well as acidity being necessary for the development of stress ulceration, there must also be damage to the gastric mucosa. This is most likely related to decrease of gastric blood flow,25 allowing necrosis to occur as the mucosa fails to protect itself against the acid environment. Conversely, increasing mucosal blood flow with isoprenaline can prevent ulceration. 27 There are many clinical situations in which gastric blood flow is decreased in critically ill patients; for example haemorrhage, sepsis, shock and drugs. High intrathoracic pressure from artificial ventilation reduces cerebral, liver and renal blood flow 2s and could conceivably decrease gastric mucosal blood flow.
It is not yet certain how mucosal ischaemia contributes to the development of stress ulcers. However, intramural pH falls considerably during haemorrhagic shock due to the impaired capacity of the mucosa to remove or buffer acid. 24 Mucosal blood flow will normally increase when luminal pH drops. This compenstation is not possible during ischaemia. Intramural pH then drops and ulceration occurs.
Mucosal barrier
The integrity of the mucosal barrier is intimately involved with mucosal blood flow and therefore cannot be separated from the factors which cause ischaemia. However, the concept of a 'mucosal barrier' is probably best defined as the property of the gastric mucosa which permits a high gradient of hydrogen ion concentration from lumen to interstitial tissue without injury to the tissue. 16 Substances which can interfere with the mucosal barrier and make the ulceration worse include bile salts and urea. Bile salts enter the stomach by reflux and urea gains access by simple diffusion in uraemic patients. 16 Both occur commonly in seriously ill patients. Aspirin and alcohol can also disrupt the mucosal barrier. 29 Finally, although the exact role of mucus is uncertain, a deficiency can predispose to acute ulceration, while an excess increases mucosal resistance. 24
CLINICAL FEATURES AND DIAGNOSIS
The incidence of endoscopically verified stress ulceration has been reported to approach Anaesthesia and !tliensi\'e Care, Vol. 13, So. 3, Augusl, 1985 100070 in critically ill patients. 2 The major clinical problems associated with ulceration are bleeding and, rarely, perforation. 22 However, only 25070 of untreated lesions show clinical signs of bleeding,5,14 and only about 5070 of patients require active resuscitation and treatment. 3,8 The incidence is slightly higher in burns patients. 11 Although bleeding can occur at any time, it is most common 4-10 days after the initial insult.
Endoscopy is the method of choice for identifying stress ulceration. As the procedure is time-consuming and the incidence of significant bleeding low, routine endoscopy in every critically ill patient is usually reserved for research purposes. Nevertheless, once significant melaena, nasogastric aspirate of 'coffee grounds' or bright blood occurs, then endoscopy should be performed to confirm the site and cause of bleeding.
In one recent series, over 50070 of critically ill patients with significant upper gastrointestinal bleeding did not have acute stress ulceration. 17
It is crucial to identify this group of patients, as their prognosis and treatment is quite different, especially if they have discrete, rather than generalised, ulceration.
Apart from macroscopic evidence of gastrointestinal bleeding, Guaiac and Hemoccult testing have been used to detect bleeding. 5 ,21 These are unreliable 21 ,30 and not relevant in the clinical situation. Apart from research purposes, it is not necessary to detect small amounts of blood loss from stress ulceration with such techniques as radioactive labelling of red cells or determination of haemoglobin content of gastric washouts.
Although Prevention of stress ulceration I, Aggressively treat any underlying disease -especially sepsis.
2,
Rapidly reverse any physiological abnormalities which decrease gastric blood flow and oxygen delivery,
3.
Institute enteral feeding whenever possible.
4.
Measure gastric pH hourly if patient not being fed.
5.
Control gastric pH>4 with either antacids or H 2 -receptor antagonists, or a combination of both.
is important therefore to concentrate on preventing stress ulceration rather than attempting to control it once it is established.
A Underlying cause
It is axiomatic that every attempt should be made to treat the factors predisposing to stress ulceration. Gastric mucosa heals promptly when the underlying cause is removed. 35 Sepsis is the commonest cause of persistent stress ulceration. 13 ,14,15 While this and some of the other predisposing factors may be difficult to reverse rapidly, every attempt should be made to maintain gastric mucosal blood flow and oxygen delivery. Hypotension, low cardiac output, hypoxia and anaemia should be corrected wherever possible. Rapid resuscitation and correction of the reversible aspects of the patient's abnormal physiology makes as much sense in the prevention of stress ulceration as it does in other areas of multiorgan failure. It is also logical to correct any coagulation abnormality which may increase the likelihood of bleeding. 21
B Enteral feeding
One of the most important findings in regard to the prevention of stress ulceration has been that enteral feeding largely prevents it. 36,37 Not only does enteral feeding satisfy nutritional requirements in the seriously ill 38 but it is as efficient as H 2 -receptor antagonists and antacids in preventing gastrointestinal bleedingY This effect has also been noted in burns patients. 39
C Miscellaneous
One should, if possible, avoid, or closely monitor, anticoagulant therapy in at-risk patients. Although steroid therapy has been associated in a recent controlled trial with increased risk of peptic ulceration and gastrointestinal haemorrhage,40 there is still controversy over the issue. 41 It has even been suggested that steroids have a beneficial effect on the gastric mucosa. 42 Their role in stress ulceration is far from resolved. D Drug Prophylaxis (i) Is prophylaxis needed? There is no doubt that the occurrence of mucosal abnormalities in untreated critically ill patients is almost universal 2 and that a small percentage of these have macroscopic bleeding. 5 . 14 However, a much smaller number actually need active treatment. 3.8 The question of whether prophylaxis is needed seemed to be resolved by the results of one of the most widely quoted prospective randomised trials 5 where 250,10 of untreated patients bled. However, even in this paper, the authors stated that the incidence of acute gastrointestinal bleeding in seriously ill patients appeared to be decreasing.
This observation is supported by other clinicians working in Intensive Care. 15 ,22,18 It could be related to increased awareness of the problem, resulting in the wider use of prophylactic measures. Alternatively, it may be due to better and more rapid resuscitation of the critically ill, the use of ventilatory techniques which result in lower mean intrathoracic pressures and thus improved extrathoracic organ blood flow, or more widespread use of enteral feeding. A recent study has demonstrated that approximately 15% of patients in Intensive Care always have a gastric pH above 4 and therefore need no prophylactic measures. 15 It may be that many of the patients with a gastric pH below 4 also do not require prophylaxis. Further trials may identify that group more precisely. Prophylactic treatment with drugs is not without complications. Furthermore, a gastric pH above 4 encourages significant overgrowth of bacteria which may be the source of high incidence of endogenous infection in the critially ill. 43 (
ii) Antacids or H 2 -receptor antagonists? a) Interpreting the trials
If prophylaxis is going to be used in the critically ill, it is usually a choice between antacids and the H2-receptor antagonists. Many of the trials designed to answer this question have been criticised. The numbers have been small, only a certain population of critically ill patients have been studied, relatively ineffective doses of either drug have been used, or the trials have not been randomised, controlled or prospective, 16, 22 Probably the most widely quoted study is from a group working at the Harvard Medical School and Beth Israel Hospital. 6 In a randomised trial on 75 critically ill patients they demonstrated antacids to be more beneficial than the H2-receptor antagonist, cimetidine. However, a clear superiority of antacids over H2-receptor antagonists has not b:en demonstrated in other trials. 16 The evaluatIOn of success depends on what end-point is chosen. Very few of the clinical studies have used serial endoscopy at that end-point. 16 More often, bleeding is used as the end-point. This raises problems of how it is detected and at what point it becomes clinically significant. The Guaiac 30 or Hemoccult test 44 have high falsepositive and false-negative rates respectively. Two of the most important trials 7,24 have been criticised because gastrointestinal bleeding taken as the end-point was not clinically significant and other causes of the bleeding were not excluded with endoscopy.21,22 Endpoints using pH are also difficult to interpret. Some studies suggest that intramural pH is more important than intraluminal pH.21 Some pH testing papers are more reliable than others. 45 However, as upper gastrointestinal bleeding has correlated so well with simple pH testing of nasogastric aspirate in most clinical trials, these differences are probably not clinically relevant. Apart from the shortcomings of the various ways of assessing the success of treatment, the outcome of a trial also depends on how often the gastric pH is measured and how compulsively drugs are titrated against that pH,15,16,22 In one widely quoted study, which showed antacids superior to cimetidine, antacids were titrated against gastric pH measured ever hour in a dose o! up to 120 mllhr, while cimetidine was given intravenously in a dose up to 400 mg every 4 hours. 6 In another trial which showed cimetidine superior to antacids, only 20 ml of antacid was given every 4 hours, while cimetidine was given continuously at a rate of 100 mg/hr Y In assessing the results of these comparative The key to prophylaxis against stress ulceration is the maintenance of a luminal intragastric pH of more than 4. 1 As both antacids and H 2 -receptor, antagonists work mainly by increasing gastric pH, this has to be frequently measured and if necessary the dose of either drug adjusted accordingly.
H 2 -receptor antagonists have been successfully used in patients with Zollinger-Ellison syndrome. 64 Because of the hypersecretion of acid in this syndrome, almost twice the daily average dose had to be used in order to control the gastric pH. Similarly, when cimetidine was used as a continuous infusion in animals, it was more effective in preventing gastrointestinal haemorrhage than antacids. 6s The wide dosage variation of ranitidine when used as a continuous infusion with boluses in critically ill patients indicates that, just like antacids, H 2 -receptor antagonists need to be effectively titrated against gastric pH rather than given in constant doses at divided intervals. IS Another way of retaining flexibility of gastric pH control is to place all at-risk patients on a standard intermittent dose of H 2 -receptor antagonist, measure the pH hourly and titrate antacids to keep the gastric pH above 4 where necessary. Not only is flexibility retained by this approach but also excessive doses of either drug are avoided. The combination of antacid and H 2 -receptor antagonists is attractive. H 2 -receptor antagonists inhibit gastric secretion as well as increasing pH.
Priebe and Skillman in a recent review suggested that the use of cimetidine as the sole prophylactic agent remains controversial but may be effective in certain groups of critically ill patients. 66 However, in general Intensive Care Units, they suggest hourly titration with antacids. A recent editorial in the New England Journal of Medicine on prophylaxis against stress ulceration takes an easier way out by simply suggesting neutralisation of the gastric contents in all at-risk patients. 67 c) Side-effects of antacids and Hrreceptor antagonists Anaesthesia and Intensive Care, Vol. 13. No. 3, Augusl, 1985 Apart from the question of which drug is most effective in preventing stress ulceration, choice is influenced by the ease of administration and reported side-effects. It is easier and less time consuming for the nursing staff to administer an intravenous drug every 4 hours than to deliver an hourly dose of antacid via a nasogastric tube. However, for flexible and effective control of the gastric pH, nasogastric contents should be aspirated and measured hourly. This largely negates any marginal difference in the time and effort needed with either regimen.
There is a relatively high incidence of minor side-effects with antacids, mainly diarrhoea and electrolyte disturbances. 6,S6 These can usually be reversed by changing to an antacid with a different composition. The incidence of diarrhoea was the same in antacid, cimetidine and placebo group in one trial 56 and another study demonstrated a significant correlation of diarrhoea with cimetidine. 68 A more serious but rare complication of antacids is concretion and impaction of accumulated antacids in the I umen of the bowel. 69, 70 This can lead to obstruction and perforation of the bowel 69 and may be precipitated by dehydration, anticholinergic drugs, narcotics, as well as the constipating effects of aluminium-based antacids. 69 ,70 Of the H 2 -receptor antagonists, cimetidine has been most widely used in the prevention of stress ulceration in Intensive Care, and has several well-documented side-effects. Cimetidine binds to cytochrome P-450 in hepatic microsomes and so reduces the clearance of many drugs, including warfarin, diazepam, phenytoin and propranolol. 71 This is particularly important for drugs with a low therapeutic index, such as warfarin and phenytoin. Ranitidine, a more recent H 2 -receptor antagonist, does not bind as avidly to the P-450 microsomal enzyme system. n Both ranitidine and cimetidine decrease liver blood flow,n but, as yet, only cimetidine has been shown to prolong the hepatic clearance of propranolol and lignocaine. n Thrombocytopenia and agranulocytosis have been reported with cimetidine 73 but not with ranitidine. Cimetidine has also been reported as causing dose-dependent confusion and mental depression 74 as well as being implicated in renal failure. 75 It could be that, because ranitidine does not bind as readily to brain receptors, nor to other cells, such as lymphocytes, it is less likely to cause side-effects. 72 However, already reports of mental confusion 76 and other adverse drug interactions, such as bradycardia after intravenous injection 72 have appeared. It may be that with increased clinical use of ranitidine a similar list of complications will occur.
A high gastric pH, whether from antacids or H2-receptor antagonists, predisposes to bacterial overgrowth. 43 In the long term these produce carcinogenic compounds. 77 More importantly, in Intensive Care the infected material is potentially dangerous to staff handling nasogastric contents and may lead to cross-infection, as well as being a source of endogenous infection. 43 (iii) Other prophylactic drugs a) Hrreceptor antagonists
Most of the trials referred to so far have used the H 2 -receptor antagonist, cimetidine. Some of the earlier studies used metiamide 78 and now more recent studies are beginning to investigate ranitidine -a new H 2 -receptor antagonist. 15, 72 Cimetidine and ranitidine produce similar short-and long-term results for the healing of duodenal ulceration. As yet there have been no controlled trials comparing either antacids or cimetidine with ranitidine for the prevention of stress ulceration. Newer H 2 -receptor antagonists, such as tiotidine, famotidine and oxmetidine, are still being clinically assessed. b) Pirenzepine
Pirenzepine is a relatively new antimuscarinic drug with anti-cholinergic effects.79 It reduces acid and pepsin secretion with a greater effect on volume than concentration. Healing of duodenal ulcer has been demonstrated 79 and there is a suggestion that when used in combination with H 2 -receptor antagonists in seriously ill patients, it contributes to the control of intragastric pH. 8o c) Substituted benzimidazoles Compounds such as omeprazole inhibit gastric acid secretion by a unique action -they selectively inhibit the K + IH + ATPase enzyme at the secretory membrane of the parietal cell. 81 Omeprazole has proved very promising in initial studies on duodenal ulcer healingY The selective and potent effect on acid production may make it eminently suitable for the prevention of stress ulceration. d) Sucralfate and bismuth compounds Sucralfate 83 is a new compound which selectively adheres to damaged mucosal areas, especially in an acid environment. Although of a different chemical structure, bismuth compounds have also been described as having a mucosal protective role, especially in the presence of acid. 84 e) Prostaglandins
One of the most exciting developments in this area has been with the use of prostaglandins. Apart from their anti-secretory action, they can also, in much smaller doses, protect the gastric mucosa, so called 'cytoprotection' . 85 They are effective against a wide range of toxic agents, including aspirin. 86 As this type of ulceration is morphologically similar to stress ulceration, there may be a future role for the prostaglandins in prophylaxis against stress ulceration. Furthermore, the action of antacids may be partly explained by the fact that they enhance the synthesis and secretion of prostaglandins. 86 f) Secretin Secretin neutralises acidity in the duodenum. It stimulates bicarbonate production from the pancreas, inhibits acid secretion and reduces gastrin. 88 However, it is not as effective as antacid in either increasing gastric pH or preventing haemorrhage. 88 E Measurement of gastric pH Although there are many techniques for monitoring gastric pH,89 the most convenient method in the clinical situation is to aspirate nasogastric contents and measure the pH with commercially available paper strips. The most reliable are Merck Universal pH Indicator strips or Lyphan Universal pH Indicator papers. 45 Hourly measurement of gastric pH with this technique correlates extremely well with continuously measured gastric pH using a pH probe. 15 Because the gastric pH varies so much, not only between patients but also in the same patient at different times, it is essential to measure the gastric pH at such frequent intervals. The effectiveness of antacids mixing with stomach contents does not seem to influence the consistency of pH readings. 90 Reliable and frequent measurement of gastric pH is the cornerstone of rational prophylactic measures against stress ulceration. 15 4. Definitive treatment of established stress ulceration As with most diseases, the best way to treat stress ulceration is to prevent it. When massive gastrointestinal bleeding occurs in critically ill patients, it carries a mortality approaching 80070. J If significant upper gastrointestinal haemorrhage is suspected it is important to confirm that it is in fact due to stress ulceration. Endoscopy in this case is mandatory as the treatment may be very different, depending on the cause. If the bleeding is clinically significant, rapid resuscitation is the first line of treatment. Adequate intravascular volume replacement with blood is essential.
TABLE 3
TreaTmenl of STress ulceraTion I.
Resuscitation.
2.
Measure gastric pH hourly.
3.
Increase intraluminal pH to >7 with either antacids of H 2 -receptor antagonists.
4.
Consider other medical and surgical manoeuvres.
5.
Reconsider reversing any precipitating factors, such as sepsis.
The intraluminal pH should then be titrated to a pH of 7 with antacids. 16 . In the majority of cases bleeding will cease with these simple measures. 16 As with the prevention of stress ulceration, H 2 -receptor antagonists may also play a role in its treatment simply by increasing the gastric pH. The success of this approach has certainly been demonstrated in patients with liver failure. 91 Although similarly promising results have been found in other series,92 none ot the trials was controlled.
Another study has shown cimetidine to be valueless in the treatment, as opposed to the prevention of bleeding. 9J A recent trial suggests that by adding an anti fibrinolytic drug (tranexamic acid), cimetidine becomes more effective. 94 Techniques such as gastric lavage with iced saline, selective angiognlphic injection with vasopressin infusion or embolisation have been used but not subjected to controlled studies. I Anaesthesia and Intensive Care, Vol. 13, No. 3, August, 1985 Continuous intravenous vasopressin has a doubtful role in upper gastrointestinal bleeding from any cause. 95 All of these techniques have a limited role, if any, in acute bleeding from stress ulceration. 16 The use of electrocoagulation and laser coagulation is limited in widespread diffuse gastric bleeding. 22 Somatostatin has recently been successfully used for control of massive upper gastrointestinal haemorrhage 96 and may eventually be shown to be useful in the treatment of stress ulceration.
Surgery should be viewed as a last resort or reserved for when perforation is suspected. I • 16 ,22 It carries a mortality of at least 70070 in most series. 16.97 In a recent review of the literature it does not appear that anyone operative procedure has an advantage over others. 97 . 98 Rebleeding rates for vagotomy and pyloroplasty are higher than those for vagotomy and gastric resection,99 but wide gastric resection has a high mortality rate. 97
